301331SZSE

Verification Opinion of the Board of Directors' Nomination and Remuneration Committee on the Adjustment of the Grant Price of Second Class Restricted Stock in the 2023 Restricted Stock Incentive Plan

Full Translation

Notes & Comments

Sign in to leave a comment or private note.

Loading…

Verification Opinion of the Board of Directors' Nomination and Remuneration Committee on the Adjustment of the Grant Price of Second Class Restricted Stock in the 2023 Restricted Stock Incentive Plan — Enwei Pharmaceutical Co., Ltd. | SZSE Releases